SEPTIN9 and brucellosis: Although it is unknown whether AUR inhibits MsF1, this difference in composition could be useful for the development of species-specific antimicrobial drugs to treat tuberculosis and other communicable diseases such as brucellosis (Brucella sp), botulism (Clostridium botulinum), cholera (Vibrio cholera), and diphtheria (Corynebacterium diphtheriae).